These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 12497044)

  • 21. pS2 (TFF1) expression in prostate carcinoma: correlation with steroid receptor status.
    Abdou AG; Aiad HA; Sultan SM
    APMIS; 2008 Nov; 116(11):961-71. PubMed ID: 19132993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
    Capitanio U; Scattoni V; Freschi M; Briganti A; Salonia A; Gallina A; Colombo R; Karakiewicz PI; Rigatti P; Montorsi F
    Eur Urol; 2008 Jul; 54(1):118-25. PubMed ID: 18314255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer.
    Sinha AA; Quast BJ; Reddy PK; Lall V; Wilson MJ; Qian J; Bostwick DG
    Exp Mol Pathol; 2004 Oct; 77(2):153-9. PubMed ID: 15351240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do all patients with high-grade prostatic intraepithelial neoplasia on initial prostatic biopsy eventually progress to clinical prostate cancer?
    Izawa JI; Lega I; Downey D; Chin JL; Luke PP
    BJU Int; 2005 Aug; 96(3):320-3. PubMed ID: 16042722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative real-time RT-PCR of CD24 mRNA in the detection of prostate cancer.
    Schostak M; Krause H; Miller K; Schrader M; Weikert S; Christoph F; Kempkensteffen C; Kollermann J
    BMC Urol; 2006 Mar; 6():7. PubMed ID: 16539730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer.
    Cardillo MR; Monti S; Di Silverio F; Gentile V; Sciarra F; Toscano V
    Anticancer Res; 2003; 23(5A):3825-35. PubMed ID: 14666684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens.
    Divrik RT; Eroglu A; Sahin A; Zorlu F; Ozen H
    Urol Oncol; 2007; 25(5):376-82. PubMed ID: 17826653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of AIbZIP and Cdc47 as markers for human prostatic diseases.
    Levesque MH; El-Alfy M; Berger L; Labrie F; Labrie C
    Urology; 2007 Jan; 69(1):196-201. PubMed ID: 17270658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A correlation of FTIR spectra derived from prostate cancer biopsies with gleason grade and tumour stage.
    Gazi E; Baker M; Dwyer J; Lockyer NP; Gardner P; Shanks JH; Reeve RS; Hart CA; Clarke NW; Brown MD
    Eur Urol; 2006 Oct; 50(4):750-60; discussion 760-1. PubMed ID: 16632188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression and significance of clusterin in normal prostate, benign prostate hyperplasia and prostate cancer].
    Zhou LQ; Yang XZ; Zeng L; Liang LL; Yang XY; Ren L; Chung L; Zhang ZW; Na YQ; Gu FL; Guo YL
    Zhonghua Wai Ke Za Zhi; 2003 Feb; 41(2):93-5. PubMed ID: 12783666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected androgen-dependent and androgen-independent cancer.
    Montironi R; Mazzucchelli R; Barbisan F; Stramazzotti D; Santinelli A; Scarpelli M; Lòpez Beltran A
    Hum Pathol; 2006 Sep; 37(9):1137-44. PubMed ID: 16938518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are repeat biopsies required in men with PSA levels < or =4 ng/ml? A Multiinstitutional Prospective European Study.
    Djavan B; Fong YK; Ravery V; Remzi M; Horninger W; Susani M; Kreuzer S; Boccon-Gibod L; Bartsch G; Marberger M
    Eur Urol; 2005 Jan; 47(1):38-44; discussion 44. PubMed ID: 15582247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic events, remodelling enzymes and their relationship to chromatin organization in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
    Mohamed MA; Greif PA; Diamond J; Sharaf O; Maxwell P; Montironi R; Young RA; Hamilton PW
    BJU Int; 2007 Apr; 99(4):908-15. PubMed ID: 17378849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic dilemmas in detection of prostate cancer in patients undergoing transrectal ultrasound-guided needle biopsy of the prostate.
    Durkan GC; Greene DR
    Prostate Cancer Prostatic Dis; 2000 Jul; 3(1):13-20. PubMed ID: 12497156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha-methylacyl-CoA racemase (AMACR) expression in normal prostatic glands and high-grade prostatic intraepithelial neoplasia (HGPIN): association with diagnosis of prostate cancer.
    Ananthanarayanan V; Deaton RJ; Yang XJ; Pins MR; Gann PH
    Prostate; 2005 Jun; 63(4):341-6. PubMed ID: 15602744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?
    Bastian PJ; Ellinger J; Schmidt D; Wernert N; Wellmann A; Müller SC; von Rücker A
    Eur J Med Res; 2004 Nov; 9(11):523-7. PubMed ID: 15649863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of a novel biomarker, EPCA, in adenocarcinomas and precancerous lesions in the prostate.
    Uetsuki H; Tsunemori H; Taoka R; Haba R; Ishikawa M; Kakehi Y
    J Urol; 2005 Aug; 174(2):514-8. PubMed ID: 16006883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular cancer phenotype in normal prostate tissue.
    Schlomm T; Hellwinkel OJ; Buness A; Ruschhaupt M; Lübke AM; Chun FK; Simon R; Budäus L; Erbersdobler A; Graefen M; Huland H; Poustka A; Sültmann H
    Eur Urol; 2009 Apr; 55(4):885-90. PubMed ID: 18501497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and nuclear localization of ErbB3 in prostate cancer.
    Koumakpayi IH; Diallo JS; Le Page C; Lessard L; Gleave M; Bégin LR; Mes-Masson AM; Saad F
    Clin Cancer Res; 2006 May; 12(9):2730-7. PubMed ID: 16675564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of biomarkers modulating prostate cancer angiogenesis: differential expression of annexin II in prostate carcinomas from India and USA.
    Banerjee AG; Liu J; Yuan Y; Gopalakrishnan VK; Johansson SL; Dinda AK; Gupta NP; Trevino L; Vishwanatha JK
    Mol Cancer; 2003 Oct; 2():34. PubMed ID: 14613585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.